EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Weight Loss, Pathological Changes, and Inflammatory Effects from a Short-Term Ketogenic Diet in Overweight and Obese Men with Untreated Prostate Cancer on Active Surveillance

Adeel Kaiser iD, Mohummad M Siddiqui, Jason Bosley-Smith, Shu Wang, Joseph Aryankalayil, Mark V Mishra, Alice S Ryan, Christopher R D'Adamo iD

Nutrients · 2024

DOI: 10.3390/nu16213716 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Adeel Kaiser und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD 21201, USA. Hauptthemen laut MEDLINE: Diet, Ketogenic, Prostatic Neoplasms, Obesity, Overweight. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: RRD VA, NIA NIH HHS, This clinical trial was grant supported by Mid-Atlantic Nutrition and Obesity Research Center through the National Institute of Diabetes and Digestive and Kidn….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims: Active Surveillance (AS) is a favored strategy for the management of indolent prostate cancers (PCs). Overweight and obese men harbor an increased risk of cancer progression during AS. We aim to prospectively evaluate the feasibility and outcomes of a ketogenic diet (KD) weight-loss intervention in overweight men with PC. Materials and Methods: Men with PC and a BMI > 25 kg/m2 undergoing AS were placed on an 8-week ad libitum KD program before a scheduled surveillance biopsy to assess the impact on clinical grade group (CGG). Blood ketone levels were tracked to ensure compliance. BMI, PSA, and inflammatory marker data (TNF-α, TNFR1, TNFR2, sICAM-1, sVCAM-1, IL-6, IL1-RA, CRP, and SAA) were collected before and after the KD intervention. A Shapiro–Wilk test was performed to assess the normality of all continuous study variables. Paired t-tests and Wilcoxon rank sum tests were utilized to compare normally and non-normally distributed study outcomes, respectively.

Results

Ten AS patients aged 62.1 (±5.4) years were enrolled with an average BMI of 31.7 kg/m2 (±11.8). Post-KD intervention mean blood ketone levels were 0.32 (±0.12) mmol/L with a mean BMI reduction of 7.4% (p < 0.0003). There were no meaningful changes in PSA or inflammatory biomarkers (p > 0.05). Nine patients completed re-biopsy following a KD with four patients showing no evidence of cancer; one downgraded to a lower CGG; two had unchanged CGG scores; and two had higher CGG scores compared to baseline.

Conclusions

Short-term KD interventions for BMI reduction are feasible in men undergoing AS for PC and may result in favorable pathological effects without inflammatory marker changes. Larger studies with longer follow-up are needed to explore whether KD-induced weight loss can improve clinical outcomes with AS in PC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diet, KetogenicProstatic NeoplasmsObesityOverweightWeight LossHumansMaleMiddle AgedAgedInflammationBody Mass IndexProspective StudiesFeasibility StudiesProstate-Specific AntigenKetones

Stichwörter der Autor:innen

active surveillanceinflammationketogenic dietobesityoverweightprostate cancer

Substanzen

Prostate-Specific AntigenKetones

Autor:innen und Institutionen

  • Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
  • Department of Radiation Oncology, Miami Cancer Institute, Miami, FL 33176, USA.
  • Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA.
  • Division of Urology, Department of Surgery, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
  • Center for Integrative Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
  • Department of Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA.

ORCID-Profile: Adeel Kaiser, Christopher R D'Adamo

Förderung

  • RRD VA
  • NIA NIH HHS
  • This clinical trial was grant supported by Mid-Atlantic Nutrition and Obesity Research Center through the National Institute of Diabetes and Digestive and Kidn…
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Zitieren

APA

Kaiser, A., Siddiqui, M. M., Bosley-Smith, J., Wang, S., Aryankalayil, J., Mishra, M. V., Ryan, A. S., & D'Adamo, C. R. (2024). Weight Loss, Pathological Changes, and Inflammatory Effects from a Short-Term Ketogenic Diet in Overweight and Obese Men with Untreated Prostate Cancer on Active Surveillance. Nutrients. https://doi.org/10.3390/nu16213716

Vancouver

Kaiser A, Siddiqui MM, Bosley-Smith J, Wang S, Aryankalayil J, Mishra MV, et al. Weight Loss, Pathological Changes, and Inflammatory Effects from a Short-Term Ketogenic Diet in Overweight and Obese Men with Untreated Prostate Cancer on Active Surveillance. Nutrients. 2024. doi:10.3390/nu16213716

BibTeX
@article{Kaiser2024,
  author = {Kaiser, Adeel and Siddiqui, Mohummad M and Bosley-Smith, Jason and Wang, Shu and Aryankalayil, Joseph and Mishra, Mark V and Ryan, Alice S and D'Adamo, Christopher R},
  title = {Weight Loss, Pathological Changes, and Inflammatory Effects from a Short-Term Ketogenic Diet in Overweight and Obese Men with Untreated Prostate Cancer on Active Surveillance},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16213716}
}
Kostenlos starten →